UVLrx Therapeutics' Unattributed - II Round

UVLrx Therapeutics raised a round of funding on September 23, 2014.

UVLrx Therapeutics aims to provide a much more comfortable, effective and affordable UBI therapy to ALL patients who want to benefit from immune system support. UVLrx technology is the only system tha…

Articles about UVLrx Therapeutics' Unattributed - II Round: